Hong Zhan
UCL Great Ormond Street Institute Of Child Health
London, ENG WC1N1EH, United Kingdom
London, ENG WC1N1EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.
Journal: Science translational medicine
Published: August 19, 2026
Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant options.
Journal: Haematologica
Published: January 20, 2024
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia.
Journal: The New England journal of medicine
Published: June 14, 2023
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia.
Journal: Science translational medicine
Published: October 26, 2022
Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis.
Journal: Acta neuropathologica
Published: August 11, 2016
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.
Journal: Science translational medicine
Published: July 08, 2016
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient.
Journal: Journal of hepatology
Published: June 04, 2014
Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene.
Journal: PloS one
Published: May 13, 2013
Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: February 26, 2013
22q11.2 deletion syndrome with life-threatening adenovirus infection.
Journal: The Journal of pediatrics
Published: January 06, 2013
Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.
Journal: Human gene therapy
Published: August 23, 2012
Last Updated: 09/26/2026